
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
1 competitor in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
View Full LandscapeTarget Indication
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Clinical Trial
NCT07608354Last updated: 7/7/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Hypercholesterolemia
Healthy Japanese Children Age 2 Years Through 6 Years
Generalized Anxiety Disorder
Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer